Biolife Solutions Inc (NASDAQ: BLFS) has seen a rise in its stock price by 11.91 in relation to its previous close of 18.01. However, the company has experienced a 11.79% gain in its stock price over the last five trading sessions. Seeking Alpha reported 2024-05-09 that Start Time: 16:30 January 1, 0000 5:02 PM ET BioLife Solutions, Inc. (NASDAQ:BLFS ) Q1 2024 Earnings Conference Call May 09, 2024, 16:30 PM ET Company Participants Rod de Greef – Chairman and CEO Troy Wichterman – CFO Garrie Richardson – Chief Revenue Officer Conference Call Participants Paul Knight – KeyBanc Hannah Hefley – Stephen Inc. Matthew Stanton – Jefferies Matt Hewitt – Craig-Hallum Capital Group Thomas Flaten – Lake Street Capital Operator Welcome to the BioLife Solutions First Quarter 2024 Financial Results and Business Update. At this time, all participants are in a listen-only mode.
Is It Worth Investing in Biolife Solutions Inc (NASDAQ: BLFS) Right Now?
Company’s 36-month beta value is 1.76.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for BLFS is 43.17M, and currently, short sellers hold a 8.24% ratio of that floaft. The average trading volume of BLFS on May 10, 2024 was 402.11K shares.
BLFS’s Market Performance
BLFS’s stock has seen a 11.79% increase for the week, with a 17.87% rise in the past month and a 8.07% gain in the past quarter. The volatility ratio for the week is 5.19%, and the volatility levels for the past 30 days are at 5.89% for Biolife Solutions Inc The simple moving average for the past 20 days is 17.79% for BLFS’s stock, with a 32.91% simple moving average for the past 200 days.
Analysts’ Opinion of BLFS
Many brokerage firms have already submitted their reports for BLFS stocks, with Jefferies repeating the rating for BLFS by listing it as a “Buy.” The predicted price for BLFS in the upcoming period, according to Jefferies is $22 based on the research report published on April 04, 2024 of the current year 2024.
Craig Hallum, on the other hand, stated in their research note that they expect to see BLFS reach a price target of $29. The rating they have provided for BLFS stocks is “Buy” according to the report published on July 11th, 2023.
Oppenheimer gave a rating of “Outperform” to BLFS, setting the target price at $28 in the report published on April 25th of the previous year.
BLFS Trading at 15.72% from the 50-Day Moving Average
After a stumble in the market that brought BLFS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -17.73% of loss for the given period.
Volatility was left at 5.89%, however, over the last 30 days, the volatility rate increased by 5.19%, as shares surge +21.15% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +18.28% upper at present.
During the last 5 trading sessions, BLFS rose by +10.87%, which changed the moving average for the period of 200-days by +2.83% in comparison to the 20-day moving average, which settled at $17.28. In addition, Biolife Solutions Inc saw 24.03% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BLFS starting from Aebersold Sarah, who sale 410 shares at the price of $16.50 back on Apr 22 ’24. After this action, Aebersold Sarah now owns 65,085 shares of Biolife Solutions Inc, valued at $6,765 using the latest closing price.
Wichterman Troy, the Chief Financial Officer of Biolife Solutions Inc, sale 956 shares at $15.31 during a trade that took place back on Apr 18 ’24, which means that Wichterman Troy is holding 126,658 shares at $14,636 based on the most recent closing price.
Stock Fundamentals for BLFS
Current profitability levels for the company are sitting at:
- -0.49 for the present operating margin
- 0.32 for the gross margin
The net margin for Biolife Solutions Inc stands at -0.46. The total capital return value is set at -0.19. Equity return is now at value -18.20, with -14.84 for asset returns.
Based on Biolife Solutions Inc (BLFS), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at -0.48. The debt to equity ratio resting at 0.09. The interest coverage ratio of the stock is -56.7.
Currently, EBITDA for the company is -45.24 million with net debt to EBITDA at -0.63. When we switch over and look at the enterprise to sales, we see a ratio of 6.82. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.89.
Conclusion
In a nutshell, Biolife Solutions Inc (BLFS) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
